DrugPatentWatch Database Preview
TERIL Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Teril patents expire, and what generic alternatives are available?
Teril is a drug marketed by Taro and is included in two NDAs.
The generic ingredient in TERIL is carbamazepine. There are twenty-seven drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
US ANDA Litigation and Generic Entry Outlook for Teril
A generic version of TERIL was approved as carbamazepine by TARO on October 3rd, 1996.
Summary for TERIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 132 |
| Patent Applications: | 4,612 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TERIL at DailyMed |
US Patents and Regulatory Information for TERIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | TERIL | carbamazepine | SUSPENSION;ORAL | 076729-001 | Sep 20, 2004 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Taro | TERIL | carbamazepine | TABLET;ORAL | 076525-001 | Sep 26, 2003 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
